Royalty Pharma plc

Listed in New York, United States.

Publicly reported facts

Location

New York, United States

Region

North America

Year founded

2020

Status

Active

Publicly listed

Yes · NASDAQ: RPRX

AUM or fund size

$25B+

Minimum investment

$100M+

Case types

Pharmaceutical royalty acquisition, Drug royalty monetization, Biopharmaceutical IP finance, Life sciences royalty streams

Geographic coverage

Global

Industry associations

LSTA, BIO

Website

royaltypharma.com

Information as publicly reported; confirm terms directly with the funder. Criterica Capital does not endorse any listed funder.

Comparing funders? Criterica Capital publishes its pricing and gives decisions in 24 to 48 hours.